Back to Search Start Over

Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis

Authors :
Goos, Jeroen A C M
de Cuba, Erienne M V
Coupé, Veerle M H
Diosdado, Begoña
Delis-Van Diemen, Pien M
Karga, Cemile
Beliën, Jeroen A M
Menke-Van der Houven van Oordt, C Willemien
Geldof, Albert A
Meijer, Gerrit A
Hoekstra, Otto S
Fijneman, Remond J A
Lam, MGEH
Borel Rinkes, IHM
van Diest, PJ
van Hillegersberg, R
Kranenburg, OW
Pathology
Other Research
Epidemiology and Data Science
CCA - Biomarkers
Urology
Radiology and nuclear medicine
Medical oncology
Source :
Goos, J A C M, de Cuba, E M V, Coupe, V M H, Karga, C, Belien, J A M, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A, Menke, C W, van Diemen, P M & Diosdado Calvo, MB 2016, ' Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis ', Annals of Surgery, vol. 263, no. 1, pp. 138-145 . https://doi.org/10.1097/SLA.0000000000001109, Annals of Surgery, 263(1), 138. Lippincott Williams and Wilkins, Annals of Surgery, 263(1), 138-145. Lippincott Williams and Wilkins
Publication Year :
2016

Abstract

OBJECTIVE: To investigate the individual and combined prognostic value of HIF1α, SLC2A1, and vascular endothelial growth factor A (VEGFA) in a multi-institutional cohort of patients with resected colorectal cancer liver metastasis (CRCLM). BACKGROUND: In the majority of patients with CRCLM, resection seems not to be curative, despite its curative intent. Overexpression of hypoxia-inducible factor 1α (HIF1α), glucose transporter 1 (SLC2A1; also known as GLUT1), and VEGFA has been associated with tumor progression and poor prognosis of patients with colorectal cancer (CRC). METHODS: Tissue microarrays were generated using CRCLM and patient-matched primary CRC from patients who underwent CRCLM resection between 1990 and 2010. Prognostic value of HIF1α, SLC2A1, and VEGFA was determined by immunohistochemistry. A 500-fold cross-validated hazard rate ratio (HRRav) for overall survival was calculated. RESULTS: HIF1α, SLC2A1, and VEGFA expression could be evaluated in 328, 350, and 335 patients, respectively. High SLC2A1 expression was associated with good prognosis (HRRav, 0.67; P (HRR >1) < 0.01) and high VEGFA expression to poor prognosis (HRRav, 1.84; P (HRR < 1) = 0.02), also after multivariate analysis including established clinicopathological prognostic variables (HRRav, 0.67; P (HRR > 1) < 0.01 and HRRav, 1.50; P (HRR < 1) = 0.02, respectively). SLC2A1 showed prognostic value particularly in patients treated with systemic therapy (P < 0.01), whereas the prognostic value of VEGFA expression was mainly observed in patients not treated with systemic therapy (P < 0.01). Prognosis was especially poor in patients with both low SLC2A1 and high VEGFA expression (P < 0.01). HIF1α expression was not associated with survival. CONCLUSIONS: SLC2A1 and VEGFA expression are prognostic molecular biomarkers for patients with CRCLM with added value to established clinicopathological variables.

Details

Language :
English
ISSN :
00034932
Database :
OpenAIRE
Journal :
Goos, J A C M, de Cuba, E M V, Coupe, V M H, Karga, C, Belien, J A M, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A, Menke, C W, van Diemen, P M & Diosdado Calvo, MB 2016, ' Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis ', Annals of Surgery, vol. 263, no. 1, pp. 138-145 . https://doi.org/10.1097/SLA.0000000000001109, Annals of Surgery, 263(1), 138. Lippincott Williams and Wilkins, Annals of Surgery, 263(1), 138-145. Lippincott Williams and Wilkins
Accession number :
edsair.doi.dedup.....60a6aa878cfc657ba27497e52cd57ccc